Understanding patient needs in switching from biologic to biosimilar medicines

The Patients Association | December 2018 | Understanding patient needs in switching from biologic to biosimilar medicines: Final report of survey and focus group findings

Understanding patient needs in switching from biologic to biosimilar medicines: Final report of survey and focus group findings, is a report from The Patients Association which finds that patients with conditions such as rheumatoid arthritis and ulcerative colitis are being switched to new medicines without being informed. 

Biologic drugs are administered by injection or infusion because they are proteins that
are quickly digested and inactivated if given by mouth. Therefore, biologic drugs are
supplied as powders for infusion or solutions for injection.

pexels-photo-356054.jpeg

The Patients Association reports that in their sample survey of patients (n=262)  and a focus group (n=7) who use biologic medicine- a  sub-set of these 69 had been switched to biosimilars, and more than one in three of these patients reported that they had not been consulted by their doctor prior to the change (Source : The Patients Association)

Read the report from The Patients Association

“Patients are being let down when they need to be supported” [press release]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s